Conquering melanoma and skin cancer

Melanoma and Skin Cancer Trials (MASC Trials) specialises in investigator-initiated melanoma and skin cancer research.

We work collaboratively with world-leading researchers to deliver clinical trials that improve melanoma and skin cancer outcomes.

0

Trials

0

Hospital
Trial Sites

0

Countries

0

Patients
Enrolled

MASC Trials 2023 Annual Scientific Meeting

23 March 2023
Brisbane Convention and Exhibition Centre

Bringing together leading figures in melanoma and skin cancer clinical trials to share the latest findings and foster further innovative research.

Clinical trials save lives - donate today

Melanoma and skin cancer do not discriminate. These cancers affect young and old, men and women, in big cities and in small towns.

Donate now and support our most promising researchers to find cures for melanoma and skin cancers, and give survivors long and healthy lives.

What We Do

MASC Trials brings together a powerful network of almost 2,000 professionals who represent the many disciplines critical to our work – oncologists, surgeons, radiation specialists, nurses, allied health professionals, health economists, statisticians, research scientists, clinical research associates, data managers, patient advocates and others.

With expert support from our Advisories and our trials staff, MASC Trials leads and designs research and clinical trial development, and provides project management for multicentre, national and international collaborations.

Collaboration drives outcomes

Recruiting Trials

Active Trials Closed for Recruitment

Trials in Start-Up Phase

Completed Trials

Research Proposals

TWITTER

LATEST NEWS

OUR PARTNERS